During chronic infection, these PD1+ T cells represent an exhausted state of T cells 38, probably leading to decreased tumor responses to anti-PD1 immunotherapy, as relatively low tumor response to PD1 inhibitor pembrolizumab is observed in HCC with HBV infection or HCV infection 28. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.